Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis.

What the trial testedas reported · 2018

Not counted

−0.21−0.36 to −0.07

As reported

difference −0.215, 95% CI −0.36 to −0.07

Range includes no effect

−4%−8% to +1%

Smaller than almost all for cardiovascular events

As reported

RR 0.96, 95% CI 0.92–1.01

the abstract, start to end

… did [standard difference in means = -0.215; 95% confidence interval (CI) …

… had no effect on total mortality (RR = 0.96; 95% CI, 0.92-1.01), but it …

← favours treatmentfavours comparator →

could be chance

Lipids

−0.215−0.36 to −0.07

Cardiovascular events

RR 0.960.92–1.01

StatinsOther lipid agentsLipidsCardiovascular events

1 / 3

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled itcites it